IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $207,000 | -42.7% | 5,596 | -42.5% | 0.01% | -39.1% |
| Q1 2022 | $361,000 | +28.5% | 9,739 | +5.4% | 0.02% | +35.3% |
| Q4 2021 | $281,000 | -35.8% | 9,239 | -29.3% | 0.02% | -41.4% |
| Q3 2021 | $438,000 | -3.7% | 13,060 | +14.6% | 0.03% | -6.5% |
| Q2 2021 | $455,000 | -18.0% | 11,399 | -7.7% | 0.03% | -24.4% |
| Q1 2021 | $555,000 | -20.5% | 12,348 | 0.0% | 0.04% | -24.1% |
| Q4 2020 | $698,000 | +197.0% | 12,348 | +209.8% | 0.05% | +145.5% |
| Q2 2020 | $235,000 | -56.8% | 3,986 | -65.4% | 0.02% | -61.4% |
| Q1 2020 | $544,000 | +156.6% | 11,516 | +228.2% | 0.06% | +216.7% |
| Q4 2019 | $212,000 | -8.2% | 3,509 | -9.1% | 0.02% | -10.0% |
| Q3 2019 | $231,000 | -6.9% | 3,861 | 0.0% | 0.02% | -4.8% |
| Q2 2019 | $248,000 | +2.5% | 3,861 | +29.4% | 0.02% | 0.0% |
| Q1 2019 | $242,000 | – | 2,983 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |